Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq™ 2.0 and an in-house method

Commercial HIV-1 genotypic resistance assays are very expensive, particularly for use in resource-constrained settings like India. Hence a cost effective in-house assay for drug resistance was validated against the standard ViroSeq™ HIV-1 Genotyping System 2.0 (Celera Diagnostics, CA, USA). A total...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Saravanan, S., Vidya, M., Balakrishanan, P., Kumarasamy, N., Solomon, Sunil S., Solomon, S., Kantor, Rami, Katzenstein, David, Ramratnam, Bharat, Mayer, Kenneth H.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2009
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2923210/
https://ncbi.nlm.nih.gov/pubmed/19490976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jviromet.2009.03.021
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge